MIC
BIIB icon

MU Investments Company’s Biogen BIIB Stock Holding History

MU Investments Company’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-300
Closed -$83K – 203
2015
Q3 		$83K Sell
300
-1,070
-78% -$353K 0.05% 224
2015
Q2 		$543K Sell
1,370
-130
-9% -$52.2K 0.26% 67
2015
Q1 		$647K Sell
1,500
-80
-5% -$31.5K 0.3% 64
2014
Q4 		$541K Buy
1,580
+100
+7% +$32.4K 0.23% 75
2014
Q3 		$489K Sell
1,480
-280
-16% -$92.3K 0.24% 78
2014
Q2 		$560K Sell
1,760
-100
-5% -$30.1K 0.26% 72
2014
Q1 		$547K Sell
1,860
-300
-14% -$95.2K 0.25% 77
2013
Q4 		$608K Sell
2,160
-140
-6% -$36.2K 0.26% 78
2013
Q3 		$563K Sell
2,300
-650
-22% -$145K 0.27% 74
2013
Q2 		$616K Buy
+2,950
New +$630K 0.26% 106

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MU Investments Company's BIIB Position: Q4 2015 in Review

MU Investments Company sold out of Biogen (BIIB) in Q4 2015, closing a stake of 300 shares — an estimated $83K sold.

MU Investments Company first reported a position in BIIB in Q2 2013 and held it in 10 quarters. The position peaked at $647K in Q1 2015. 970 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • MU Investments Company reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
  • MU Investments Company sold 300 Biogen shares in Q4 2015, an estimated $83K.
  • MU Investments Company first reported a position in Biogen in Q2 2013 and held it in 10 quarters.
  • MU Investments Company's Biogen position peaked at $647K in Q1 2015.
  • 970 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on MU Investments Company's 13F filing for Q4 2015, filed 28 Jan 2016.